{"id":"124i-at-01","safety":{"commonSideEffects":[{"rate":"null","effect":"Hypotension"},{"rate":"null","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL4303347","moleculeType":"Small molecule","molecularWeight":"455.60"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting LAL, 124I-AT-01 aims to reduce the accumulation of cholesterol and triglycerides in cells, potentially treating lysosomal acid lipase deficiency.","oneSentence":"124I-AT-01 is a small molecule targeting the lysosomal acid lipase (LAL) enzyme.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:19:06.826Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Lysosomal acid lipase deficiency"}]},"trialDetails":[{"nctId":"NCT06974877","phase":"PHASE1","title":"Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-09-10","conditions":"Cryopyrin-Associated Periodic Syndromes, Amyloidosis","enrollment":30},{"nctId":"NCT05758493","phase":"PHASE2","title":"Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2023-01-10","conditions":"Amyloidosis, Transthyretin Amyloidosis","enrollment":150},{"nctId":"NCT05235269","phase":"PHASE2","title":"A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis","status":"COMPLETED","sponsor":"Attralus, Inc.","startDate":"2021-11-30","conditions":"Amyloidosis","enrollment":33},{"nctId":"NCT05635045","phase":"PHASE2","title":"Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR","status":"COMPLETED","sponsor":"Columbia University","startDate":"2022-07-08","conditions":"Transthyretin Amyloidosis","enrollment":10},{"nctId":"NCT06907849","phase":"PHASE2","title":"124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"University of Tennessee Graduate School of Medicine","startDate":"2025-05","conditions":"Lumbar Spinal Stenosis, Carpal Tunnel Syndrome (CTS), Cardiac Amyloidosis","enrollment":40},{"nctId":"NCT05968846","phase":"PHASE2","title":"Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load","status":"COMPLETED","sponsor":"University of Tennessee Graduate School of Medicine","startDate":"2022-12-07","conditions":"Systemic Amyloidosis","enrollment":19}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["AT-01","I124-AT-01"],"phase":"phase_2","status":"active","brandName":"124I-AT-01","genericName":"124I-AT-01","companyName":"Attralus, Inc.","companyId":"attralus-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"124I-AT-01 is a small molecule targeting the lysosomal acid lipase (LAL) enzyme. Used for Lysosomal acid lipase deficiency.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}